The Journal of Immunology, Vol 145, Issue 10 3276-3282, Copyright © 1990 by American Association of Immunologists

ARTICLES

Identification of sites within gp41 that serve as targets for antibody- dependent cellular cytotoxicity by using human monoclonal antibodies

DS Tyler, SD Stanley, S Zolla-Pazner, MK Gorny, PP Shadduck, AJ Langlois, TJ Matthews, DP Bolognesi, TJ Palker and KJ Weinhold
Department of Surgery, Duke University Medical Center, Durham, NC 27710.

In an effort to determine the functional activity of anti-HIV-1 human mAb and to define the epitopes against which they are directed, supernatants from 10 EBV-transformed lymphoblastoid cell lines producing mAb to HIV were tested. Five clones producing mAb to gp41 and five producing mAb to p24 were identified. The anti-HIV-1 human mAb were tested in neutralization and cell fusion assays in the form of cell culture supernatants at concentrations ranging from 1.7 to 22.0 micrograms/ml. None of the human mAb were found either to inhibit HIV-1- (IIIB or RF) associated cell fusion or to neutralize HIV-1 (IIIB) infection of AA5 cells. All human mAb were additionally tested in 6 h 51Cr release assays for their ability to direct HIV-1 specific antibody- dependent cellular cytotoxicity (ADCC). For ADCC assays, PBMC were isolated from healthy seronegative donors and used as effector cells. HIV-1 infected (IIIB, RF, and MN) CEM.NKR cells as well as CEM.NKR cells with purified gp120 adsorbed onto their surface served as targets. None of the anti-p24 mAb mediated ADCC. In contrast, three of the anti-gp41 mAb were able to direct a significant level of ADCC against each of the infected targets, but as expected, failed to lyse gp120 adsorbed cells. To define the specific epitopes against which the anti-gp41 mAb were directed, seven small peptides homologous to regions within the extracellular domain of gp41 were synthesized. Using RIA, two of the mAb could be mapped. The most effective ADCC-directing human mAb bound to a peptide comprising amino acids 644-663, whereas the least effective ADCC directing anti-gp41 human mAb bound to a region within the immunodominant portion of gp41 outlined by amino acids 579- 604. Together, these results for the first time assign a functional activity to human mAb directed at specific regions within gp41 by demonstrating that areas within this molecule can serve as targets for ADCC.

This article has been cited by other articles:

				S. M. Alam, R. M. Scearce, R. J. Parks, K. Plonk, S. G. Plonk, L. L. Sutherland, M. K. Gorny, S. Zolla-Pazner, S. VanLeeuwen, M. A. Moody, et al. Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection J. Virol., January 1, 2008; 82(1): 115 - 125. [Abstract] [Full Text] [PDF]

				R. A. McCaffrey, C. Saunders, M. Hensel, and L. Stamatatos N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies J. Virol., April 1, 2004; 78(7): 3279 - 3295. [Abstract] [Full Text] [PDF]

				T. Yamada, N. Watanabe, T. Nakamura, and A. Iwamoto Antibody-Dependent Cellular Cytotoxicity via Humoral Immune Epitope of Nef Protein Expressed on Cell Surface J. Immunol., February 15, 2004; 172(4): 2401 - 2406. [Abstract] [Full Text] [PDF]

				D. ENSHELL-SEIJFFERS, L. SMELYANSKI, N. VARDINON, I. YUST, and J. M. GERSHONI Dissection of the humoral immune response toward an immunodominant epitope of HIV: a model for the analysis of antibody diversity in HIV+ individuals FASEB J, October 1, 2001; 15(12): 2112 - 2120. [Abstract] [Full Text] [PDF]

				M. K. Gorny and S. Zolla-Pazner Recognition by Human Monoclonal Antibodies of Free and Complexed Peptides Representing the Prefusogenic and Fusogenic Forms of Human Immunodeficiency Virus Type 1 gp41 J. Virol., July 1, 2000; 74(13): 6186 - 6192. [Abstract] [Full Text]

				P. S. Polacino, V. Stallard, J. E. Klaniecki, S. Pennathur, D. C. Montefiori, A. J. Langlois, B. A. Richardson, W. R. Morton, R. E. Benveniste, and S.-L. Hu Role of Immune Responses against the Envelope and the Core Antigens of Simian Immunodeficiency Virus SIVmne in Protection against Homologous Cloned and Uncloned Virus Challenge in Macaques J. Virol., October 1, 1999; 73(10): 8201 - 8215. [Abstract] [Full Text] [PDF]

				O. Alsmadi and S. A. Tilley Antibody-Dependent Cellular Cytotoxicity Directed against Cells Expressing Human Immunodeficiency Virus Type 1 Envelope of Primary or Laboratory-Adapted Strains by Human and Chimpanzee Monoclonal Antibodies of Different Epitope Specificities J. Virol., January 1, 1998; 72(1): 286 - 293. [Abstract] [Full Text] [PDF]